| Everolimus 5 mg/day (n = 12) | Everolimus 10 mg/day (n = 12) |
---|---|---|
Ongoing, n (%) | 2 (16.7) | 1 (8.3) |
Discontinued, n (%) | 10 (83.3) | 11 (91.7) |
   Patient withdrew consent | 1 (8.3) | 2 (16.7) |
   Death | 0 | 2 (16.7) |
   Disease progression | 9 (75.0) | 7 (58.3) |